NHL | SCC | p value | |
---|---|---|---|
Qualitative Imaging Findings on CT | (n = 12) | (n = 29) | |
Predominant growth pattern | |||
Permeative | 6 (50)a | 3 (10) | |
Destructive | 4 (33) | 24 (83)aa | |
Expansile | 2 (17) | 2 (7) | |
Remaining sinus wall within the tumor | 11 (92)a | 10 (34) | 0.001 |
Intratumoral necrosis | 2 (17) | 25 (86)aa | < 0.001 |
Cervical lymphadenopathy | 4 (33) | 4 (14) | 0.158 |
Tumor extension | |||
Nasal cavity | 9 (75) | 22 (76) | 0.622 |
Orbit | 6 (50) | 19 (66) | 0.281 |
Subcutaneous tissue | 9 (75) | 17 (59) | 0.266 |
Retroantral fat pad | 10 (83) | 24 (83) | 0.672 |
Pterygoid process | 2 (17) | 10 (34) | 0.226 |
Perineural spread | 1 (8) | 6 (21) | 0.323 |
Intracranial | 1 (8) | 3 (10) | 0.668 |
Quantitative Measurements on MRI | (n = 4) | (n = 17) | |
T1–weighted images | 0.89 ± 0.09 | 0.96 ± 0.18 | 0.457 |
T2–weighted images | 1.10 ± 0.21 | 1.07 ± 0.25 | 0.813 |
Diffusion-weighted images | 1.64 ± 0.68 | 1.13 ± 0.31 | 0.227 |
ADC (×10−3 mm2/s) | 0.61 ± 0.09aaa | 0.95 ± 0.12 | < 0.001 |
Quantitative Measurements on PET/CT | (n = 7) | (n = 15) | |
SUVmax | 20.8 ± 7.4 | 17.4 ± 5.4 | 0.517 |